Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): 201627008488
Who filed: Low Cost Standard Therapeutics
Country: India
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 28-12-2022
Patent type: Combination

Click within the document, or manually enter the page number below

Low Cost Standard Therapeutics opposition, Glecaprevir / Pibrentasvir, (201817002543)

Countries: India Date: 2022
Sankalp Rehabilitation Trust opposition, Bemnifosbuvir hemisulfate, (201917029812)

Countries: India Date: 2022
Natco Pharma Ltd. opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)

Countries: India Date: 2014
Indian Pharmaceutical Alliance (IPA) opposition, sofosbuvir (GS7977) , (3658/KOLNP/2009)

Countries: India Date: 2014
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)

Countries: India Date: 2014
Natco Pharma Ltd. opposition, sofosbuvir (GS7977) , (3658/KOLNP/2009)

Countries: India Date: 2014
Sankalp Rehabilitation Trust opposition, sofosbuvir (GS7977) , (6087/DELNP/2005)

Countries: India Date: 2015
Sankalp Rehabilitation Trust, Hepatitis C Coalition of Nagaland (HepCon) and Asia Network of Positive People (APN+) opposition, Sofosbuvir , (3658/KOLNP/2009)

Countries: India Date: 2014
India Cares Foundation opposition, Sofosbuvir, (6087/DELNP/2005)

Countries: India Date: 2015
Optimus Pharma Ltd. opposition, Sofosbuvir, (6087/DELNP/2005)

Countries: India Date: 2015

Low Cost Standard Therapeutics Opposition, Sofosbuvir/Velpatasvir, (201627008488)